Terrestrial is developing the Tacterra™ microarray patch (MAP) platform, capable of delivering a wide range of therapies through the skin, enabling precise dose delivery without injections
Terrestrial is developing the Tacterra™ microarray patch (MAP) platform, capable of delivering a wide range of therapies through the skin, enabling precise dose delivery without injections.